Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013

PloS One
M Imöhl, M van der Linden

Abstract

A nationwide laboratory-based surveillance study of invasive S. pyogenes infections was conducted in Germany. Invasive isolates (n = 1,281) were obtained between 2003 and 2013. All isolates were susceptible to penicillin, cefotaxime and vancomycin. Tetracycline showed the highest rate of resistant or intermediate resistant isolates with 9.8%, followed by macrolides (4.0%), trimethoprim/sulfamethoxazole (SXT) (1.9%), levofloxacin (1.3%), chloramphenicol (0.9%) and clindamycin (0.7%). The most prominent trends were the appearance of levofloxacin non-susceptible isolates since 2011, and an increase of SXT non-susceptibility since 2012.

References

Mar 1, 1995·Antimicrobial Agents and Chemotherapy·B Weisblum
Dec 1, 1993·The Journal of Antimicrobial Chemotherapy·H SeppäläP Huovinen
Jul 25, 2000·Clinical Microbiology Reviews·M W Cunningham
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Eleonora GiovanettiPietro Emanuele Varaldo
Oct 29, 2005·The Lancet Infectious Diseases·Jonathan R CarapetisMartin Weber
Sep 8, 2006·Journal of Clinical Microbiology·Katarzyna SzczypaWaleria Hryniewicz
Nov 10, 2006·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·B Weisblum
Oct 26, 2007·Journal of Clinical Microbiology·Bogdan Luca-HarariAftab Jasir
May 9, 2008·Journal of Clinical Microbiology·Theresa L LamagniAftab Jasir
Sep 8, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·T TakahashiUNKNOWN Invasive Streptococcal Disease Working Group
Feb 12, 2010·FEMS Immunology and Medical Microbiology·Matthias ImöhlMark van der Linden
Jun 22, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T SiljanderJ Vuopio
Mar 23, 2011·International Journal of Antimicrobial Agents·Christine BleyRalf René Reinert
Apr 15, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M MontesE Pérez-Trallero
Sep 3, 2011·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C PlainvertUNKNOWN CNR-Strep network
Aug 22, 2012·Antimicrobial Agents and Chemotherapy·C Silva-CostaUNKNOWN Portuguese Group for the Study of Streptococcal Infections
Oct 12, 2012·Journal of Clinical Microbiology·Asha C BowenJonathan R Carapetis
Aug 13, 2013·International Journal of Medical Microbiology : IJMM·Ana FriãesUNKNOWN Portuguese Group for the Study of Streptococcal Infections
Aug 24, 2013·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·M MeehanR Cunney
Jun 21, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Dennis L StevensJames C Wade
Mar 10, 2015·Expert Review of Anti-infective Therapy·Catarina Silva-CostaJose Melo-Cristino
Sep 1, 2005·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·T L Lamagni Strep-Euro

❮ Previous
Next ❯

Citations

Apr 28, 2016·The Journal of Antimicrobial Chemotherapy·Athanasios MichosVassiliki P Syriopoulou
Dec 20, 2016·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Sonia KsiaAmel Kechrid
Feb 13, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jamie L W RhoadsVanessa W Stevens
Apr 22, 2017·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B OlzowyUNKNOWN Working Party ‘Antimicrobial Resistance’ of the Paul-Ehrlich-Society for Chemotherapy
Dec 6, 2020·Current Opinion in Infectious Diseases·Philippe Montravers, Christian Eckmann
Jun 26, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Katherine FayChris A Van Beneden

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Software Mentioned

R

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Cellulitis

Cellulitis (erysipelas) is a recurring and debilitating bacterial infection of the skin and underlying tissue. Discover the latest research on cellulitis here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.